You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Orion Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ORION PHARMA, and what generic and branded alternatives to ORION PHARMA drugs are available?

ORION PHARMA has two approved drugs.

Summary for Orion Pharma

US Patents:	0
Tradenames:	7
Ingredients:	2
NDAs:	2

Drugs and US Patents for Orion Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Orion Pharma	STALEVO 150	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-003	Jun 11, 2003	AB	RX	Yes	No		⤷ Subscribe				⤷ Subscribe
Orion Pharma	STALEVO 200	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-004	Aug 2, 2007	AB	RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Orion Pharma	COMTAN	entacapone	TABLET;ORAL	020796-001	Oct 19, 1999	AB	RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Orion Pharma	STALEVO 75	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-005	Aug 29, 2008	AB	RX	Yes	No		⤷ Subscribe				⤷ Subscribe
Orion Pharma	STALEVO 125	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-006	Aug 29, 2008	AB	RX	Yes	No		⤷ Subscribe				⤷ Subscribe
Orion Pharma	STALEVO 50	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-001	Jun 11, 2003	AB	RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Orion Pharma	STALEVO 100	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-002	Jun 11, 2003	AB	RX	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Orion Pharma

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Orion Pharma	STALEVO 200	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-004	Aug 2, 2007	5,135,950	⤷ Subscribe
Orion Pharma	STALEVO 100	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-002	Jun 11, 2003	6,500,867	⤷ Subscribe
Orion Pharma	STALEVO 150	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-003	Jun 11, 2003	4,963,590	⤷ Subscribe
Orion Pharma	STALEVO 50	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-001	Jun 11, 2003	6,797,732	⤷ Subscribe
Orion Pharma	STALEVO 75	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-005	Aug 29, 2008	6,500,867	⤷ Subscribe
Orion Pharma	STALEVO 150	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-003	Jun 11, 2003	6,797,732	⤷ Subscribe
Orion Pharma	STALEVO 200	carbidopa; entacapone; levodopa	TABLET;ORAL	021485-004	Aug 2, 2007	5,446,194	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ORION PHARMA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	200 mg	➤ Subscribe	2007-04-11
➤ Subscribe	Tablets	18.75 mg/75 mg/200 mg and 31.25 mg/125 mg/200 mg	➤ Subscribe	2009-05-19
➤ Subscribe	Tablets	50 mg/200 mg/200 mg	➤ Subscribe	2008-08-28
➤ Subscribe	Tablets	18.75 mg/75 mg/200 mg and 31.25 mg/125 mg/200 mg	➤ Subscribe	2009-05-19
➤ Subscribe	Tablets	25/100/200 mg and 37.5/150/200 mg	➤ Subscribe	2007-06-29
➤ Subscribe	Tablets	25/100/200 mg and 37.5/150/200 mg	➤ Subscribe	2007-06-29
➤ Subscribe	Tablets	12.5 mg, 50 mg and 200 mg	➤ Subscribe	2008-08-05

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Orion Pharma

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.